Sentrx to Exhibit at the 46th DIA Annual Meeting June 13-17, 2010 in Washington, DC

LITTLE FALLS, N.J.--(BUSINESS WIRE)-- Sentrx, the leading provider of drug safety services to the life science industry, will exhibit at the upcoming 46thDIA Annual Meeting, June 13-17, 2010 in Washington, DC. Sentrx will be featuring CROplus, a comprehensive channel partner solution for growth oriented clinical research organizations as well as their full service pharmacovigilance and drug safety solutions. Visit Sentrx at booth #2039 at DIA to learn how their services and solutions enhance and optimize pharmacovigilance and drug safety needs.

Sentrx will have onsite experts from its Pharmacovigilance unit, as well as members of their Medical Affairs and Regulatory Affairs service departments. Also available will be member of Sentrx Technology Services Group to discuss recent trends and developments in safety technology, including Oracle’s safety roadmap and the implication of the proposed Phase Forward acquisition.

The DIA Annual Meeting is the premier event for professionals involved in the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products. There is no other industry meeting of its kind that can rival the breadth and depth of experience that this meeting delivers. With 25 content-area tracks, 330 sessions, and 20 tutorials, presentations are geared to attendees at all disciplines, works settings, and experience levels.

About Sentrx

We are drug safety experts. Our highly experienced teams focus in safety technology systems, adverse event management and medical affairs. Sentrx solutions are customized, integrated and scalable to improve efficiency, reduce cost, and improve flexibility. Our experience is unmatched, built over 15 years serving a broad range of bio-pharmaceutical clients, including CROs.

To learn more about Sentrx, visit www.sentrx.com.

About the Drug Information Association (DIA)

DIA is a neutral, global, professional, member-driven association of nearly 18,000 industry, academia, and regulatory professionals involved in the discovery and development of pharmaceuticals, medical devices, and related products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China.



CONTACT:

Sentrx
Janice Scheider, 973-826-1824
[email protected]

KEYWORDS:   United States  North America  District of Columbia  New Jersey

INDUSTRY KEYWORDS:   Health  Biotechnology  Medical Devices  Pharmaceutical  Other Health  Research  Other Science  Science  General Health

MEDIA:

Logo
 Logo

Suggested Articles

Solid Bio fixed the manufacturing issue that led to a partial clinical hold on its DMD trial, but a full hold remains.

Commissioner Scott Gottlieb has laid out the reasons why he thinks the FDA needs a double-digit budget bump.

GW's cannabis-based epilepsy drug scored a favorable review from FDA staff ahead of an expert panel meeting.